1. Home
  2. Southern Africa
  3. South Africa
  • News

Daunting challenge for AIDS drug rollout

After getting the long awaited go-ahead from cabinet to start a national antiretoviral (ARV) programme, South Africa's health department is now faced with the daunting challenge of drawing up a strategy for distributing the anti-AIDS drugs to the millions of people who need them. Senior health department officials met on Monday to discuss a rollout plan of ARV drugs to public hospitals, health department spokesman Sibani Mngadi told PlusNews. This meeting followed last week's instruction by the cabinet to the department to urgently develop an operational plan for a national treatment programme by 30 September 2003. "The department is working on a detailed operational plan, and one of the things we will be looking at is procurement [of ARVs]," Mngadi said. A joint health department and treasury task team called for the establishment of a "strong" national price negotiating team and strategy to obtain the drugs at the best possible prices. The task team also recommended encouraging the granting of voluntary licences by patent holders for local manufacture. Local pharmaceutical company Aspen Pharmacare last week launched the drug, Aspen-Stavudine, its generic version of Zerit, made by Bristol-Myers Squibb, saying it would be immediately available to any HIV-positive citizens who need it. Stavudine is one of the key drugs used in a triple therapy cocktail The company was granted voluntary licences by Bristol-Myers Squibb to produce generic versions of the drug in South Africa. Under the terms of the agreement, Aspen Pharmacare can sell its version of the drug to both public and private patients across Africa. According to group chief operating officer Linda Philip, the government would possibly put out tenders for the supply of the drugs. "But hopefully they will also pay attention to the local manufacture of the drugs as a way of building capacity in the [pharmaceutical] industry," Philip told PlusNews. It was, however, too early to determine from where the drugs would be sourced, she noted. "The government is certainly aware of our capability and capacity. Hopefully this will provide an opportunity for South Africa to look towards home-based solutions," she added.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Get the day’s top headlines in your inbox every morning

Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

It’s the perfect way to start your day.

Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join